Dockets Home | Accessibility | Dockets Contacts and Location | Operating Status | Item Codes
DOCKETS ENTERED on 1/6/03
Docket Number - Title
00P-1378 Cosmetic Products Containing Alpha Hydroxy Acids *
02D-0266 Guidance preventive measures to reduce risk of (CJD) *
02D-0324 Bioengineered Plants for Use in Humans and Animals *
02D-0389 Nonclinical Studies for Development of Pharmaceutical Excipi *
02N-0417 Applications for FDA Approval to Market a New Drug *
02N-0518 International Conference on Harmonisation Meetings in Japan *
03P-0006 Determine if Levorphanol Tartrate withdrawn for safety reaso *
95N-0071 Proposal to Debar Amirul Islam; Notice of Opportunity for He
LET 3 Zuckerman Spaeder, LLP Vol#: 1
LET 4 London & Mead Vol#: 1
96D-0041 Clinical Safety Data Management: Safety Update Reports
GDL 1 GUIDANCE Vol#: 1
NAD 3 Vol#: 1
00D-1538 Electronic Records; Electronic Signatures, Validation
LST 12 Gen. References for Guidance 01/06/03 Vol#: 8
00D-1539 Electronic Records & Signatures, Retention of Electronic Rec
LST 12 Gen. References for Guidance 01/06/03 Vol#: 8
00D-1540 Electronic Signatures, Electronic Copies of Electronic Recor
LST 12 Gen. References for Guidance 01/06/03 Vol#: 6
00D-1541 Electronic Signatures: Audit Trails
LST 12 Gen. References for Guidance 01/06/03 Vol#: 6
00D-1542 Electronic Signatures: Time Stamps
LST 12 Gen. References for Guidance 01/06/03 Vol#: 6
00D-1543 Electronic Signatures: Glossary of Terms
LST 12 Gen. References for Guidance 01/06/03 Vol#: 7
00N-1596 Uniform Compliance Date for Food Labeling Regulations
NFR 2 Vol#: 1
00P-1378 Cosmetic Products Containing Alpha Hydroxy Acids
02D-0266 Guidance preventive measures to reduce risk of (CJD)
C 15 Heartland Lions Eye Banks (HLEB) Vol#: 1
C 16 University of Miami Vol#: 1
02D-0324 Bioengineered Plants for Use in Humans and Animals
C 201 Ray Wade Vol#: 6
C 202 Ken Maloney & Julie Ford-Maloney Vol#: 6
C 203 Sister Anne-Marie Baurqui, RSM Vol#: 6
C 204 Daniel C. Shively Vol#: 6
C 205 David Seaborg Vol#: 6
C 206 Michele Wuensch Vol#: 6
C 207 Jenny Jones Vol#: 6
C 208 Louise Hetzker Vol#: 6
C 209 Elizabeth & Sean Cortez-Mathis Vol#: 6
C 210 Richard Kark Vol#: 6
C 211 Marjory M. Donn Vol#: 6
C 212 Charles R. Zalac Vol#: 6
C 213 National Jewish Medical and Research Cen Vol#: 6
C 214 Effie E. Westervelt Vol#: 6
C 215 Betty Hutchinson Vol#: 6
C 216 Ty Conley Vol#: 6
C 217 John Bass Vol#: 6
C 218 Barbara Byrd Vol#: 6
C 219 Rita Bonasera Vol#: 6
C 220 Mort Cohen Vol#: 6
C 221 Adorers of the Blood of Christ Vol#: 6
C 222 Donald Danforth Plant Science Center Vol#: 6
C 223 Lucinda A. Caldwell Vol#: 6
C 224 Phyllis Pryzby Vol#: 6
C 225 Bob Giambalvo Vol#: 6
C 226 Patricia DeFerrari, PhD Vol#: 6
C 227 Rebecca Kimbell Vol#: 6
C 228 Margaret McBride Vol#: 6
C 229 Joyce Frohn Vol#: 6
C 230 L.D. Pratt Vol#: 6
C 231 Mary Ann S. Clymer Vol#: 6
C 232 Sandra R. Shmookler Vol#: 6
C 233 Charles & Lindsey Shere Vol#: 6
C 234 Lora Chamberlain Vol#: 6
C 235 Dave Rich Vol#: 6
C 236 Nancy W. Lienke Vol#: 6
C 237 Ben R. Gilbert Vol#: 6
C 238 Ann Amyes Vol#: 6
C 239 Gerald Geci Vol#: 6
C 240 Dini Schut Vol#: 6
C 241 Annapoorne Colangelo Vol#: 6
02D-0389 Nonclinical Studies for Development of Pharmaceutical Excipi
02N-0417 Applications for FDA Approval to Market a New Drug
C 30 National Assn of Chain Drug Stores Vol#: 4
C 31 State of New York Dept of Health Vol#: 4
C 32 Consumers Union (CU) Vol#: 4
02N-0518 International Conference on Harmonisation Meetings in Japan
NM 1 Meeting on 1/21/03 Vol#: 1
03P-0006 Determine if Levorphanol Tartrate withdrawn for safety reaso
ACK 1 HFA-305 to Lachman Consultant Services Vol#: 1
CP 1 Lachman Consultant Services, Inc. Vol#: 1
03V-0005 Laser Light Show
ACK 1 HFA-305 Vol#: 1
VAR 1 Baton Rouge Communications Vol#: 1